(Q35033439)

English

A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

10

object named as

R S Herbst

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

E Massarelli

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

D D Liu

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

J J Lee

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

M Wolf

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

A Fandi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

J Ochs

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

T Le Chevalier

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

F Fossella

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 January 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

39

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

55-61

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900308-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900308-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Locally advanced, unresectable non-small cell lung cancer: new treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900308-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Management Issues for Stage IV Non-Small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900308-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900308-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900308-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Second-line chemotherapy in relapsing or refractory non-small-cell lung cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900308-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900308-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900308-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900308-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(02)00308-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12499095%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35033439&oldid=1923801600"